Veterinary Drug terms — page 13 | HESTIA Glossary

Browse all 1,061 veterinary drug terms HESTIA uses to describe agricultural data — with definitions and synonyms. Free and open.

Levorphanol 17-Methylmorphinan-3-ol; levorphanol; Levorphan; Aromarone; Methorphinan; Racemethorphanum; Antalgin; Cetarin; Dromoran; Racemic dromoran; Methorfinan [Czech]; Levorfanolo [DCIT]; Orphan; 17-Methylmorphinan-3-ol; Levorfanol [INN-Spanish]; Levorphanolum [INN-Latin]; Racemorfano [INN-Spanish]; N-Methyl-3-hydroxymorphinan; Racemorphan; Racemorphan [INN:BAN]; Racemorphane [INN-French]; Racemorphanum [INN-Latin]; (-)-N-Methylmorphinan-3-ol; Levorphanal; Morphinan-3-ol, 17-methyl-; dl-3-Hydroxy-N-methylmorphinan; Ro 1-5431; 77-07-6; DEA No. 9220; DEA No. 9733; L-morphan; (+-)-17-Methylmorphinan-3-ol; (-)-3-Hydroxy-N-methylmorphinan; NU 2206; UNII-27618J1N2X; HSDB 3349; Morphinan, 3-hydroxy-17-methyl-; (+-)-3-Hydroxy-N-methylmorphinan; EINECS 201-002-6; EINECS 206-048-0; CHEMBL592; CHEBI:6444; LEVORPHANOL HYDROCHLORIDE; JAQUASYNZVUNQP-USXIJHARSA-N; 1,3,4,9,10,10a-Hexahydro-11-methyl-2H-10,4a-iminoethanophenanthren-6-ol, dl-mixture; 27618J1N2X; Morphinan-3-ol, 17-methyl-, (-)-; Levorfanolo; Levorphanolum; Methorfinan; Racemorfano; Racemorphane; Racemorphanum; Levodroman; Levorfanol; Morphinan-3-ol, 17-methyl-, (+-)-; Morphinan, 3-hydroxy-N-methyl-, (+-)-; L-Dromoran; 1,3,4,9,10,10a-Hexahydro-11-methyl-2H-10,4a-iminoethanophenanthren-6-ol, l-; 2H-10, 4a-Iminoethanophenanthren-6-ol, 1,3,4,9,10,10a-hexahydro-11-methyl-, dl-; 2H-10,4a-Iminoethanophenanthren-6-ol, 1,3,4,9,10,10a-hexahydro-11-methyl-, l-; Dextro-Dromoran; 2H-10,4a-Iminoethanophenanthren-6-ol, 1,3,4,9,10,10a-hexahydro-11-methyl-; Levorphanol dl-form; Levorphanol (INN); Levorphanol [INN:BAN]; (+)-N-Methylmorphinan-3-ol; ( -)-N-Methylmorphinan-3-ol; (+-)-N-Methylmorphinan-3-ol; d-Form of levorphanol; LEVORPHANOL-tartarate; SCHEMBL24335; GTPL7595; IDS-NL-007; DTXSID3023213; BDBM82427; (+)-cis-1,3,4,9,10,10a-Hexahydro-11-methyl-2H-10,4a-iminoethanophenanthren-6-ol; (-) 3-hydroxy-N-methylmorphinan; BDBM224028; ZINC3812984; BDBM50017233; BDBM50369518; 17-Methylmorphinan-3-ol, (+)- #; DB00854; 297-90-5; LS-91821; LS-92022; CAS_5985-38-6; C08014; D08123; Q2579108; UNII-V7R79HN3XD component JAQUASYNZVUNQP-USXIJHARSA-N; 9.alpha.,13.alpha.,14.alpha.-Morphinan-3-ol, 17-methyl-; Morphinan-3-ol, 17-methyl-, (9.alpha.,13.alpha.,14.alpha.)-; (1R,9R,10R)-17-methyl-17-azatetracyclo[7.5.3.0^{1,10}.0^{2,7}]heptadeca-2(7),3,5-trien-4-ol; Levorphanol; Aromarone
Levulinic acid 4-Oxo-pentanoic acid; Levulinic acid; 4-03-00-01560 (Beilstein Handbook Reference)
Lidocaine 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide; lidocaine; 137-58-6; Lignocaine; Xylocaine; 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide; Lidoderm; Anestacon; Esracaine; Duncaine; Alphacaine; Cappicaine; Gravocain; Isicaina; L-Caine; Leostesin; Maricaine; Xylocain; Xylocitin; Solcain; Isicaine; Xylestesin; Rucaina; Xilina; Xycaine; Xylotox; Cito optadren; Lida-Mantle; Dalcaine; 2-(Diethylamino)-2',6'-acetoxylidide; Xyloneural (free base); Cuivasil; Dentipatch; Jetocaine; Lignocainum; Octocaine; Remicaine; Xilocaina; Xllina; 2-Diethylamino-N-(2,6-dimethylphenyl)acetamide; Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-; Lidocaine (VAN); Diethylaminoaceto-2,6-xylidide; ELA-Max; Xilocaina [Italian]; alpha-Diethylamino-2,6-dimethylacetanilide; Lidocainum [INN-Latin]; Lidocaina [INN-Spanish]; EMBOLEX; 2',6'-Acetoxylidide, 2-(diethylamino)-; Lidocaton; alfa-Dietilamino-2,6-dimetilacetanilide; CHEBI:6456; HSDB 3350; UNII-98PI200987; Xylocaine (TN); CHEMBL79; EINECS 205-302-8; NSC 40030; LIDOPEN; alfa-Dietilamino-2,6-dimetilacetanilide [Italian]; BRN 2215784; C14H22N2O; MLS000069724; NNJVILVZKWQKPM-UHFFFAOYSA-N; NSC-40030; N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide; N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide; .alpha.-Diethylaminoaceto-2,6-xylidide; NCGC00015611-10; Xylesthesin; Dilocaine; Lidocaina; Lidocaine, 97.5%; Lidocainum; SMR000058189; .alpha.-(Diethylamino)-2,6-acetoxylidide; .alpha.-Diethylamino-2,6-dimethylacetanilide; .omega.-Diethylamino-2,6-dimethylacetanilide; 2-(Diethylamino)-N-(2,6-dimethylphenyl)-acetamide; 98PI200987; DSSTox_CID_25166; DSSTox_RID_80716; DSSTox_GSID_45166; N-(2,6-Dimethylphenyl)-N2,N2-diethylglycinamide; 2-(Diethylamino)-N-(2,6-Dimethylphenyl)ethanamide; Lidocaine Hydrocarbonate; Versatis; Ztilido; Lidocaine Base; ZTlido; Lidocaine Monohydrochloride; Xylocaine CO2; Dentipatch (TN); CAS-137-58-6; LQZ; Lidocaine [USAN:INN:JAN]; Qualigens; Xyline; Lignocaine base; LidocaineHClH2O; Lidocaine [USP:INN:BAN:JAN]; Lidocaine, powder; 2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide; Zingo (Salt/Mix); MFCD00026733; Lidocaine(Alphacaine); CDS1_000283; Lidocaine (Alphacaine); Spectrum_001118; Lidothesin (Salt/Mix); Xyloneural (Salt/Mix); Opera_ID_385; Maybridge1_002571; Prestwick0_000050; Prestwick1_000050; Prestwick2_000050; Prestwick3_000050; Spectrum2_001343; Spectrum3_001392; Spectrum4_000070; Spectrum5_001549; Lopac-L-5647; Lidaform HC (Salt/Mix); Epitope ID:116205; Lidamantle HC (Salt/Mix); 2', 2-(diethylamino)-; Neosporin Plus (Salt/Mix); Lopac0_000669; SCHEMBL15689; BSPBio_000179; BSPBio_001359; BSPBio_003004; KBioGR_000079; KBioGR_000599; KBioSS_000079; KBioSS_001598; 4-12-00-02538 (Beilstein Handbook Reference); MLS000758263; MLS001074177; MLS001423964; N1-(2,6-dimethylphenyl)-N2,N2-diethylglycinamide; ARONIS23855; BIDD:GT0342; Diethylaminoacet-2,6-xylidide; DivK1c_000174; DivK1c_001323; Lidocaine, analytical standard; Alphacaine; Xylocaine; lignocaine; SPBio_001525; SPBio_002100; Lidocaine (JP17/USP/INN); ALGRX 3268; ALGRX-3268; BPBio1_000197; GTPL2623; DTXSID1045166; SCHEMBL17967359; CTK3J2126; HMS548M19; KBio1_000174; KBio2_000079; KBio2_001598; KBio2_002647; KBio2_004166; KBio2_005215; KBio2_006734; KBio3_000157; KBio3_000158; KBio3_002224; ZINC20237; Lidocaine 1.0 mg/ml in Methanol; NINDS_000174; Bio1_000379; Bio1_000868; Bio1_001357; Bio2_000079; Bio2_000559; HMS1791D21; HMS1989D21; HMS2051C21; HMS2089E15; HMS2235O14; HMS3371J04; HMS3393C21; HMS3428O07; HMS3651G09; BCP09081; HY-B0185; KS-000046GY; NSC40030; Tox21_110183; ANW-42187; BBL005525; BDBM50017662; LS-805; s1357; SBB080556; STK552033; AKOS001026768; Tox21_110183_1; CCG-100824; CS-2070; DB00281; MCULE-9294700940; NC00074; RTR-031283; SB19118; SDCCGSBI-0050648.P005; WLN: 2N2 & 1VMR B1 F1; .alpha.-Diethylamino-2,6-acetoxylidide; CAS-73-78-9; IDI1_000174; IDI1_033829; NCGC00015611-01; NCGC00015611-02; NCGC00015611-03; NCGC00015611-04; NCGC00015611-05; NCGC00015611-06; NCGC00015611-07; NCGC00015611-08; NCGC00015611-09; NCGC00015611-11; NCGC00015611-12; NCGC00015611-13; NCGC00015611-14; NCGC00015611-15; NCGC00015611-16; NCGC00015611-18; NCGC00022176-05; NCGC00022176-06; NCGC00022176-07; NCGC00022176-08; NCGC00022176-09; AC-10282; AS-13718; CPD000058189; M620; SAM001247018; SC-19460; ST023341; 2-(Diethylamino)-2'',6''-acetoxylidide; SBI-0050648.P004; AB2000065; Lignocaine base 100 microg/mL in Methanol; TR-031283; AB00053581; FT-0082378; FT-0600570; L0156; SW196598-4; A18187; C07073; D00358; J10173; K-4450; AB00053581-27; AB00053581-28; AB00053581_29; AB00053581_30; Q216935; (2,6-dimethylphenyl)carbamoylmethyl-diethyl-azanium; N1-(2,6-dimethylphenyl)-2-(diethylamino)acetamide; W-108233; 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide #; BRD-K52662033-001-02-6; BRD-K52662033-003-05-5; BRD-K52662033-003-14-7; Z55135799; Lidocaine, British Pharmacopoeia (BP) Reference Standard; Lidocaine, European Pharmacopoeia (EP) Reference Standard; N~1~-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide; Lidocaine, United States Pharmacopeia (USP) Reference Standard; Lidocaine, Pharmaceutical Secondary Standard; Certified Reference Material; Lidocaine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; 91484-71-8; LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE); 6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE)); Lidocaine; 4-12-00-02538 (Beilstein Handbook Reference)
Lincomycin Methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-D-erythro-alpha-D-galacto-octopyranoside; Lincomycin; BRN 0707677
Lincosamides Clindamycin; Lincomycin; Pirlimycin
Linezolid N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide; linezolid; 165800-03-3; Zyvox; (S)-N-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide; Zyvoxid; PNU-100766; Zyvoxam; U-100766; PNU 100766; U 100766; UNII-ISQ9I6J12J; C16H20FN3O4; HSDB 7478; N-(((S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide; CHEMBL126; ISQ9I6J12J; N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide; CHEBI:63607; TYZROVQLWOKYKF-ZDUSSCGKSA-N; Linezolid, 98%; N-[[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide; CPD000466335; (S)-N-[[3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide; Acetamide, N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-; N-{[(5s)-3-(3-Fluoro-4-Morpholin-4-Ylphenyl)-2-Oxo-1,3-Oxazolidin-5-Yl]methyl}acetamide; Q-201308; Zivoxid; Zyvoxa; Linezolid [USAN:INN]; (S)-N-[[3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide; Acetamide, N-(((5S)-3-(3-fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)-; Acetamide, N-((3-(3-fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)-, (S)-; N-[[(5S)-3-(3-fluoro-4-morpholino-phenyl)-2-oxo-oxazolidin-5-yl]methyl]acetamide; N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide; SMR000466335; ZLD; Zyvox (TN); SR-01000759376; Linezolid & VRC3375; Linezoid; Linezolid (JAN/USAN/INN); Linezolid [USAN:INN:BAN]; MFCD00937825; NCGC00164628-01; Linezolid (Zyvox); AK105905; N-({(5S)-3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide; N-{[(5S)-3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide; 111GE017; NDA 21-130 Zyvox (linezolid tablets); N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide; SCHEMBL5027; DSSTox_CID_26489; DSSTox_RID_81660; DSSTox_GSID_46489; MLS000759444; MLS001424075; BIDD:GT0404; Benzotriazol-2-yl-acetonitrile; cid_441401; Linezolid (PNU-100766); QCR-88; DTXSID5046489; Linezolid, >=98% (HPLC); NDA 21-131 Zyvox for injection (linezolid injection); SYN3021; HMS2051F08; HMS2089K06; HMS3260C14; HMS3713K10; NDA 21-132 Zyvox oral suspension (linzolid oral suspension); BCP05586; KS-00000BB5; ZINC2008866; Tox21_112246; Tox21_500096; BDBM50116067; GA2609; s1408; AKOS016340522; AM84567; BCP9000855; CCG-101009; CS-0756; DB00601; KS-1178; NC00259; (R)-N-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide; NCGC00260781-01; NCGC00263531-03; NCGC00263531-10; CC-29960; HY-10394; N-({5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide, N-[[(S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide; SAM001246624; SC-11638; AB0012049; AX8042607; LS-173594; ST2408359; CAS-165800-03-3; FT-0080803; FT-0602524; SW197639-3; C08146; D00947; J90009; M-8338; AB00639994-06; AB00639994-08; AB00639994-09; AB00639994_10; AB00639994_11; 800L033; A810662; C-20237; Q411377; SR-01000759376-4; SR-01000759376-5; U-100,766; Linezolid, United States Pharmacopeia (USP) Reference Standard; (S)-N-((3-fluoro-4-morpholinophenyl)-2-oxaoxazolidin-5-yl)methyl)acetamide; Linezolid, Pharmaceutical Secondary Standard; Certified Reference Material; (Linezolid)N-[3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide; (S)-N-((3-(3-fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide; (S)-N-[ [3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-oxazolidin-5-yl]methyl]-acetamide; (S)-N-[[3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide; N-[(R)-3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide; N-[(S)-3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide; N-[3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide; N-[3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide(linezolid); (S)-3-(3-Fluoro-4-morpholin-4-yl-phenyl)-5-[(1-hydroxy-ethylamino)-methyl]-oxazolidin-2-one; N-((S)-2-oxo-3-(S)-2,3,3a,4-tetrahydro-1H-benzo[b]pyrrolo[1,2-d][1,4]oxazin-7-yl-oxazolidin-5-ylmethyl)-acetamide; N-[[(5S)-3-(3-fluoranyl-4-morpholin-4-yl-phenyl)-2-oxidanylidene-1,3-oxazolidin-5-yl]methyl]ethanamide; Linezolid; Linezolid
Linolenic acid (9Z,12Z,15Z)-9,12,15-Octadecatrienoic acid; Linolenic acid; AI3-23986
Lipoic acid (3R)-1,2-Dithiolane-3-pentanoic acid; Thioctic acid, d form; (R)-1,2-Dithiolane-3-pentanoic acid
Lipopeptide antibiotics Daptomycin
Lomefloxacin 1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; Lomefloxacin; BRN 4210041
Lomustine N-(2-Chloroethyl)-N'-cyclohexyl-N-nitrosourea; lomustine; 13010-47-4; 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea; Belustine; CCNU; CeeNU; Cecenu; CINU; Chloroethylcyclohexylnitrosourea; Urea, N-(2-chloroethyl)-N'-cyclohexyl-N-nitroso-; LomustiLomustinum; Lomustinum [INN-Latin]; Lomustina [INN-Spanish]; N-(2-Chloroethyl)-N'-cyclohexyl-N-nitrosourea; 1-(2-Chloroethyl)-3-cyclohexylnitrosourea; Gleostine; Cyclohexyl chloroethyl nitrosourea; SRI 2200; NSC 79037; NSC-79037; ICIG 1109; NCI-C04740; NSC79037; (Chloro-2-ethyl)-1-cyclohexyl-3-nitrosourea; RB 1509; (Cloro-2-etil)-1-cicloesil-3-nitrosourea; UNII-7BRF0Z81KG; C9H16ClN3O2; CCRIS 860; Lomustine (CeeNU); 1-Nitrosourea, 1-(2-chloroethyl)-3-cyclohexyl-; CHEBI:6520; CCNU [Chloroethyl nitrosoureas]; Urea, 1-(2-chloroethyl)-3-cyclohexyl-1-nitroso-; HSDB 6519; EINECS 235-859-2; BRN 2125058; 7BRF0Z81KG; (Cloro-2-etil)-1-cicloesil-3-nitrosourea [Italian]; AI3-52779; 1-(2-chloroethyl)-3-cyclohexyl-1-nitroso-urea; NCGC00167466-01; 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea [Chloroethyl nitrosoureas]; DSSTox_CID_3222; 3-(2-chloroethyl)-1-cyclohexyl-3-nitrosourea; DSSTox_RID_76930; DSSTox_GSID_23222; W-108355; Lomustine [USAN:BAN:INN]; CAS-13010-47-4; CeeNU (TN); SR-05000001497; Lomustine (USAN/INN); NPFAPI-06; Lomustine [USAN:INN:BAN]; CCNU; CeeNU; Lomustine, >=98%; CCN-U; CHEMBL514; NCIMech_000220; SCHEMBL3995; WLN: L6TJ AMVNNO&2G; GTPL7214; DTXSID2023222; GQYIWUVLTXOXAJ-UHFFFAOYSA-N; HMS2090A17; HMS3655I16; Pharmakon1600-01502301; BCP06551; ZINC3831006; ZX-AT016332; Tox21_112470; BDBM50247919; LS-728; NSC759635; s1840; AKOS005766022; Tox21_112470_1; AC-8062; ACN-048517; API0003206; CCG-213022; CS-1461; DB01206; DS-1269; NSC-759635; NCGC00167466-02; NCGC00167466-03; AK-72901; BR-72901; CC-30028; H651; HY-13669; NCI60_041743; SC-12119; TA-01004; AB0013165; AB2000326; DB-017097; 4CH-007422; AM20070540; FT-0083566; FT-0627972; L0251; ST24026836; SW220040-1; A-2090; C07079; D00363; AB00173884-02; AB00173884-03; AB00173884-04; AB00173884_05; AB00173884_06; 010L474; A806019; C-13733; Q415378; SR-05000001497-1; SR-05000001497-3; Urea, 1-(2-chloroethyl)-3-cyclohexyl)-1-nitroso-; Lomustine, European Pharmacopoeia (EP) Reference Standard; Lomustine, United States Pharmacopeia (USP) Reference Standard; 1-(2-Chloroethyl)-1-[(cyclohexylamino)carbonyl]-2-oxohydrazine #; 2-chloro-N-(cyclohexyl-C-hydroxycarbonimidoyl)-N-nitrosoethan-1-amine; 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea1-(2-chloroethyl)-3-cyclohexyl-1-nitroso-urea13010-47-4NCI60_0417431-(2-Chloroethyl)-3-cyclohexylnitrosourea1-Nitrosourea, 1-(2-chloroethyl)-3-cyclohexyl-Be; Lomustine; AI3-52779
Loperamide 4-(4-Chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-1-piperidinebutanamide; Loperamide; 5-21-02-00379 (Beilstein Handbook Reference)
Lovastatin (2S)-(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester butanoic acid; Lovastatin; BRN 3631989
Lupeol (3beta)-Lup-20(29)-en-3ol; Lupeol; Clerodol
Lynestrenol LYNESTRENOL; 52-76-6; Linestrenol; Ethinylestrenol; Ethynylestrenol; Lynoestrenol; Orgametril; Orgametrol; Exluton; Endometril; Exlution; ExlutoOrgametil; 3-Desoxynorlutin; Ethynloestrenol; Exluten; Lynenol; Lynstranol; Ethinyloestranol; Ethinyl oestrenol; NSC-37725; Org 485-50; IND 1006; Linestrenolo [DCIT]; 17alpha-Ethynylestrenol; 17-alpha-Ethynylestrenol; 17-alpha-Ethynyloestrenol; UNII-N2Z8ALG4U5; Linestrenol [INN-Spanish]; Lynestrenolum [INN-Latin]; CCRIS 9093; EINECS 200-151-4; Lynoestrenol [Progestins]; NSC 37725; 17.alpha.-Ethynylestrenol; 19-Norpregn-4-en-20-yn-17-ol, (17alpha)-; Estr-4-en-17beta-ol, 17-ethynyl-; N2Z8ALG4U5; 17-alpha-Ethynylestr-4-en-17-beta-ol; delta4-17alpha-Ethinylestren-17beta-ol; 17-alpha-Ethynyloestr-4-en-17-beta-ol; 17-alpha-Ethinyl-17-beta-hydroxyestr-4-ene; 19-Nor-17alpha-pregn-4-en-20-yn-17-ol; 17-alpha-Ethinyl-17-beta-hydroxyoestr-4-ene; CHEBI:31790; 17-alpha-Ethynil-delta-4-estrene-17-beta-ol; (17-alpha)-19-Norpregn-4-en-20-yn-17-ol; delta(sup 4)-17-alpha-Ethinylestren-17-beta-ol; delta(sup 4)-17-alpha-Ethinyloestren-17-beta-ol; NSC37725; 19-Norpregn-4-en-20-yn-17-ol, (17.alpha.)-; (8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol; 19-norpregn-4-en-20-yn-17alpha-ol; Estr-4-en-17.beta.-ol, 17-ethynyl-; 19-Nor-17-alpha-pregn-4-en-20-yn-17-ol; 19-Nor-17.alpha.-pregn-4-en-20-yn-17-ol; .DELTA.4-17.alpha.-Ethinylestren-17.beta.-ol; 19 Norpregn-4-en-20-yn-17-ol, (17alpha)-; Linesterol; Linestrenolo; Lynestrenolum; Lynestrenol [USAN:INN:JAN]; HSDB 7899; (17alpha)-17-ethynylestr-4-en-17-ol; Lynestrenol [USAN:INN:BAN:JAN]; Prestwick_533; Prestwick0_000095; Prestwick1_000095; Prestwick2_000095; Prestwick3_000095; Lynestrenol (JAN/USAN); SCHEMBL37816; BSPBio_000050; SPBio_001989; 17-Ethynylestr-4-en-17-ol; BPBio1_000056; CHEMBL2107431; YNVGQYHLRCDXFQ-XGXHKTLJSA-N; HMS1568C12; HMS2095C12; HMS3712C12; BCP04136; NSC73879; ZINC3875355; LMST02030127; NSC-73879; s4883; AKOS024462708; 19-Nor-4-pregnen-20-yn-17beta-ol; CCG-220095; DB12474; LS-7125; NCGC00179676-01; AK161684; SC-47263; L0246; ST24047514; 19-Norpregn-4-en-20-yn-17-ol, (17a)-; C13037; D01580; 052L766; 19-Nor-17alpha-pregn-4-en-20-yn-17-ol (8CI); Q2071071; 3-Desoxynorlutin
Lysergide (8 beta)-9,10-Didehydro-N,N-diethyl-6-methylergoline-8-carboxamide; LSD; 4-25-00-00939 (Beilstein Handbook Reference)
MISOPROSTOL misoprostol; 59122-46-2; Cytotec; Isprelor; Misoprostolum [INN-Latin]; SC-29333; Misodel; SC 29333; CCRIS 6859; HSDB 3573; BRN 4155643; NCGC00162445-02; Misoprostil; Misoprostolum; Misoprost; Misotol; methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate; Misogon; Misopess; Misotac; GyMiso; Cytotec (TN); Methyl (+-)-11-alpha,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate; misoprostol (methyl ester); (11-alpha,13E)-(+-)-11,16-Dihydroxy-16-methyl-9-oxoprost-13-en-1-oic acid methyl ester; SR-01000695425; Misoprostol (JAN/USAN/INN); XP-16J; methyl (11alpha,13E)-11,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate; MVI 200; Prost-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (11alpha,13E)-; (+-)-Methyl (1R,2R,3R)-3-hydroxy-2-((E)-(4RS)-4-hydroxy-4-methyl-1-octenyl)-5-oxocyclopentaneheptanoate; methyl 7-((1R,2R,3R)-3-hydroxy-2-((E)-4-hydroxy-4-methyloct-1-enyl)-5-oxocyclopentyl)heptanoate; 11|A-Misoprostol; CAS_59122-46-2; Misoprostol [USAN:USP:INN:BAN:JAN]; DSSTox_CID_897; CHEMBL606; SCHEMBL7787; DSSTox_RID_75852; DSSTox_GSID_20897; MLS000028863; GTPL1936; DTXSID7020897; BDBM85606; CHEBI:94387; Misoprostol, >=99% (HPLC); OJLOPKGSLYJEMD-URPKTTJQSA-N; REGID_for_CID_5282381; HMS2090L10; HMS3648F03; HMS3715K08; EX-A1774; HY-B0610; Prost-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (11alpha,13E)-(+-)-; MISOPROSTOL (1%) DISPERSION; Tox21_112010; MFCD00274550; (+/-)-15-Deoxy-(16RS)-16-hydroxy-16-methylprostaglandin E1 methyl ester; AKOS015899652; CCG-221093; CS-2828; DB00929; SMP1_000193; NCGC00162445-01; NCGC00162445-03; SC-17968; SMR000058558; CAS-59122-46-2; D00419; AB00513745-05; 122M462; A832173; Q416025; Q-201409; SR-01000695425-2; SR-01000695425-4; BRD-A50310035-001-01-6; Misoprostol, European Pharmacopoeia (EP) Reference Standard; Misoprostol, United States Pharmacopeia (USP) Reference Standard; (+/-) methyl 11alpha, 16-dihydroxy-16-methyl-9-oxoprost-13E-en-1-oate; (+/-) methyl 11alpha,16-dihydroxy-16-methyl-9-oxoprost-13E-en-1-oate; (+/-) methyl-11alpha,16-dihydroxy-16-methyl-9-oxoprost-13E-en-1-oate; (+/-) methyl-11alpha,16-dihydroxy-16-methyl-9-oxoprost13E-en-1-oate; (+/-)-(11a,13E)-11,16-Dihydroxy-16-methyl-9-oxo-prost-13-en-1-oic acid methyl ester; (11alpha,13E)-11,16-Dihydroxy-16-methyl-9-oxoprosta-13-ene-1-oic acid methyl ester; Misoprostol for system suitability, European Pharmacopoeia (EP) Reference Standard; Prost-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester,(11a,13E)-; 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoic acid methyl ester; methyl 7-((1R,2R,3R)-3-hydroxy-2-((E)-4-hydroxy-4-methyloct-1-en-1-yl)-5-oxocyclopentyl)heptanoate; methyl 7-[(1R,2R,3R)-2-[(E)-4-methyl-4-oxidanyl-oct-1-enyl]-3-oxidanyl-5-oxidanylidene-cyclopentyl]heptanoate; methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(1E)-4-hydroxy-4-methyloct-1-en-1-yl]-5-oxocyclopentyl]heptanoate; Misoprostol; BRN 4155643
Macrolides and ketolides Ketolide; Azithomycin; Cethromycin; Clarithromycin; Dirithromycin; Erythromycin; Fidaxomicin; Flurithromycin; Gamithromycin; Josamycin; Kitasamycin; Midecamycin; Miocamycin; Oleandomycin; Rokitamycin; Roxithromycin; Spiramycin; Telithromycin; Tildipirosin; Tilmicosin; Troleandomycin; Solithromycin; Tulathromycin; Tylosin; Tylvalosin
Magnesium hydroxide Magnesium hydroxide (Mg(OH)2); Magnesium hydroxide; S/G 84
Malachite green N-[4-[[4-(Dimethylamino)phenyl]phenylmethylene]-2,5-cyclohexadien-1-ylidene]-N-methylmethanaminium chloride (1:1); Malachite green; C.I. 42000
Malachite green cation N-[4-[[4-(Dimethylamino)phenyl]phenylmethylene]-2,5-cyclohexadien-1-ylidene]-N-methylmethanaminium; Malachite green; Ammonium, (4-(p-(dimethylamino)-alpha-phenylbenzylidene)-2,5-cyclohexadien-1-ylidene)dimethyl-
Maleic acid (Z)-2-Butenedioic acid; cis-Butenedioic acid; 4-02-00-02199 (Beilstein Handbook Reference)
Malonaldehyde Propanedial; Malondialdehyde; MALONALDEHYDE; Propanedial; Malonyldialdehyde; Malonodialdehyde; Malonic aldehyde; Malonic dialdehyde; 1,3-Propanedial; 1,3-Propanedione; 542-78-9; 1,3-Propanedialdehyde; UNII-4Y8F71G49Q; CCRIS 5168; HSDB 4353; CHEBI:566274; NCI-C54842; BRN 1209262; 4Y8F71G49Q; MDD; Propanedial (9CI); beta-ketopropionaldehyde; Epitope ID:140943; 4-01-00-03634 (Beilstein Handbook Reference); CHEMBL446036; CTK1H0902; DTXSID90202556; WSMYVTOQOOLQHP-UHFFFAOYSA-N; ZINC5178380; DB03057; LS-1344; CC-30132; ZINC000005178380; C19440; 132018-EP2295435A1; C-00026; Q418661; MALONALDEHYDE (SEE ALSO MALONALDEHYDE SODIUM SALT 24382-04-5); Malonaldehyde; 4-01-00-03634 (Beilstein Handbook Reference)
Malonamic acid 3-Amino-3-oxopropanoic acid; Malonamic acid; EINECS 219-069-5
Malonate Propanedioic acid ion(2-); Malonic acid, ion(2-); BRN 3904386
Malonic acid 4-02-00-01874 (Beilstein Handbook Reference)
Mandelic acid (+-)-alpha-Hydroxybenzeneacetic acid
Manganese(2+) Mn(II); Manganese(2+); Manganese(II); Manganous ion; Manganese (Mn2+); Mn2+; Manganese ion(2+); Manganese cation; MANGANESE(II) ION; Manganese, ion (Mn2+); Manganese(2+)ions; Manganese cation (2+); UNII-H6EP7W5457; 16397-91-4; Mn(II); Mn++; Mn(2+); H6EP7W5457; 15365-82-9; manganese ion; Manganous cation; Manganese dication; Manganous dication; manganese (II); MnII; Manganese(2+) ion; Mn(II) (incorrect); ion (Mn2+); Manganese cation (Mn2+); at. no. 25; Hexaaquamanganese(2+) ion; CHEBI:29035; CTK4C7940; Manganese(2+), hexaaqua-, ion; DTXSID00167687; WAEMQWOKJMHJLA-UHFFFAOYSA-N; DB06757; LS-89223; C19610; Q27095727; Manganese, ion (Mn2+); Manganese(2+)
Mannitol D-Mannitol; D-mannitol; mannitol; 69-65-8; Mannite; Osmitrol; Manna sugar; Osmofundin; Cordycepic acid; Mannit; Mannazucker; Mannidex; Mannigen; Mannistol; Resectisol; Diosmol; Invenex; Isotol; Osmosal; Marine Crystal; Maniton-S; Hexahydroxyhexane; D-(-)-Mannitol; Mannogem 2080; Mannitol, D-; Mannitol (VAN); Bronchitol; 87-78-5; Mannitol 5%; (2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol; Mannitol [USAN]; Mannitol 10%; Mannitol 15%; Mannitol 20%; Aridol; Mannidex 16700; (2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol; SDM No. 35; Osmitrol 5% In Water; Osmitrol 10% In Water; Osmitrol 15% In Water; Osmitrol 20% In Water; MANNITOL 25%; Resectisol In Plastic Container; Mannitol 5% In Plastic Container; NCI-C50362; Mannitol 10% In Plastic Container; Mannitol 15% In Plastic Container; Mannitol 20% In Plastic Container; UNII-3OWL53L36A; Mannitol (USP); Mannitol [USP]; CCRIS 369; BRN 1721898; HSDB 714; CHEBI:16899; NSC 9256; D-Mannitol, ACS reagent; EINECS 200-711-8; EINECS 201-770-2; MFCD00064287; OSMITROL 5% IN WATER IN PLASTIC CONTAINER; NSC 407017; OSMITROL 10% IN WATER IN PLASTIC CONTAINER; OSMITROL 15% IN WATER IN PLASTIC CONTAINER; OSMITROL 20% IN WATER IN PLASTIC CONTAINER; MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER; AI3-19511; 3OWL53L36A; Sorbitol-Mannitol; C6H14O6; 1,2,3,4,5,6-Hexanehexol; NCGC00164246-01; E421; D-Mannitol, 98+%; MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%; MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%; E-421; DSSTox_CID_3235; DSSTox_RID_76936; DSSTox_GSID_23235; MTL; manita; D-mannite; CAS-69-65-8; Osmitrol (TN); SMR000857324; SORBITOL-MANNITOL IN PLASTIC CONTAINER; SR-01000838849; D-Mannitol, EP, USP grade; Cordycepate; Manitol; D-mitobronitol; Mushroom sugar; Maniton s; Mannit p; D-Mannit; NSC-407017; Bronchitol (TN); (D)-mannitol; Mannitol,(S); cpd without stereochemical designation; D-Mannitol (Osmitrol); D-Mannitol (JP17); D-Mannitol, >=98%; M0044; SCHEMBL919; bmse000099; CHEMBL689; Epitope ID:114705; Isomalt impurity, mannitol-; 4-01-00-02841 (Beilstein Handbook Reference); ED1D1E61-FEFB-430A-AFDC-D1F4A957FC3D; MLS001335977; MLS001335978; D-Mannitol, AR, >=99%; D-Mannitol, LR, >=99%; INS NO.421; DTXSID1023235; DTXSID30858955; INS-421; FBPFZTCFMRRESA-KVTDHHQDSA-N; HMS2230N11; HY-N0378; ZINC2041302; Tox21_112092; Tox21_201487; Tox21_300483; AKOS006280947; D-Mannitol, plant cell culture tested; Tox21_112092_1; BCP9000575; CS-2494; D-Mannitol, BioXtra, >=98% (GC); DB00742; LS-1588; D-Mannitol, NIST(R) SRM(R) 920; NCGC00164246-03; NCGC00164246-04; NCGC00164246-05; NCGC00254277-01; NCGC00259038-01; AC-12776; AC-14054; AS-30501; D-Mannitol, tested according to Ph.Eur.; K167; LS-89250; SC-18306; D-Mannitol, p.a., 96.0-101.5%; D-Mannitol, SAJ first grade, >=99.0%; AB0008020; AB1002081; B2090; D-Mannitol, SAJ special grade, >=99.0%; E 421; FT-0625542; FT-0628167; S2381; SW220287-1; 1630-EP2269989A1; 1630-EP2269994A1; 1630-EP2269996A1; 1630-EP2269999A1; 1630-EP2270000A1; 1630-EP2270002A1; 1630-EP2270005A1; 1630-EP2270007A1; 1630-EP2270008A1; 1630-EP2270011A1; 1630-EP2270012A1; 1630-EP2270013A1; 1630-EP2270014A1; 1630-EP2272517A1; 1630-EP2272537A2; 1630-EP2272817A1; 1630-EP2272826A1; 1630-EP2272848A1; 1630-EP2275412A1; 1630-EP2275413A1; 1630-EP2275420A1; 1630-EP2275421A1; 1630-EP2277507A1; 1630-EP2277565A2; 1630-EP2277566A2; 1630-EP2277567A1; 1630-EP2277568A2; 1630-EP2277569A2; 1630-EP2277570A2; 1630-EP2277861A1; 1630-EP2277867A2; 1630-EP2277877A1; 1630-EP2277879A1; 1630-EP2280003A2; 1630-EP2280008A2; 1630-EP2280010A2; 1630-EP2281559A1; 1630-EP2281818A1; 1630-EP2281823A2; 1630-EP2283811A1; 1630-EP2284149A1; 1630-EP2284159A1; 1630-EP2284166A1; 1630-EP2286795A1; 1630-EP2287147A2; 1630-EP2287156A1; 1630-EP2287160A1; 1630-EP2287165A2; 1630-EP2287166A2; 1630-EP2289509A2; 1630-EP2289518A1; 1630-EP2289893A1; 1630-EP2289894A2; 1630-EP2292222A1; 1630-EP2292227A2; 1630-EP2292231A1; 1630-EP2292234A1; 1630-EP2292280A1; 1630-EP2292593A2; 1630-EP2292597A1; 1630-EP2292611A1; 1630-EP2292612A2; 1630-EP2292613A1; 1630-EP2292616A1; 1630-EP2292617A1; 1630-EP2292620A2; 1630-EP2292622A1; 1630-EP2292624A1; 1630-EP2292630A1; 1630-EP2295053A1; 1630-EP2295055A2; 1630-EP2295402A2; 1630-EP2295408A1; 1630-EP2295416A2; 1630-EP2295424A1; 1630-EP2295426A1; 1630-EP2295427A1; 1630-EP2295430A2; 1630-EP2295431A2; 1630-EP2295432A1; 1630-EP2295433A2; 1630-EP2295437A1; 1630-EP2295439A1; 1630-EP2298734A2; 1630-EP2298743A1; 1630-EP2298744A2; 1630-EP2298747A1; 1630-EP2298748A2; 1630-EP2298752A1; 1630-EP2298758A1; 1630-EP2298759A1; 1630-EP2298764A1; 1630-EP2298765A1; 1630-EP2298770A1; 1630-EP2298773A1; 1630-EP2298775A1; 1630-EP2298779A1; 1630-EP2298783A1; 1630-EP2301533A1; 1630-EP2301540A1; 1630-EP2301922A1; 1630-EP2301923A1; 1630-EP2301931A1; 1630-EP2301937A1; 1630-EP2301938A1; 1630-EP2305243A1; 1630-EP2305248A1; 1630-EP2305250A1; 1630-EP2305254A1; 1630-EP2305636A1; 1630-EP2305641A1; 1630-EP2305653A1; 1630-EP2305663A1; 1630-EP2305664A1; 1630-EP2305665A1; 1630-EP2305668A1; 1630-EP2305675A1; 1630-EP2305680A2; 1630-EP2305681A1; 1630-EP2305695A2; 1630-EP2305696A2; 1630-EP2305697A2; 1630-EP2305698A2; 1630-EP2308492A1; 1630-EP2308510A1; 1630-EP2308562A2; 1630-EP2308812A2; 1630-EP2308828A2; 1630-EP2308833A2; 1630-EP2308852A1; 1630-EP2308861A1; 1630-EP2308869A1; 1630-EP2308872A1; 1630-EP2308873A1; 1630-EP2308875A1; 1630-EP2308877A1; 1630-EP2311453A1; 1630-EP2311464A1; 1630-EP2311494A1; 1630-EP2311806A2; 1630-EP2311807A1; 1630-EP2311809A1; 1630-EP2311821A1; 1630-EP2311825A1; 1630-EP2311829A1; 1630-EP2311831A1; 1630-EP2311836A1; 1630-EP2311837A1; 1630-EP2311838A1; 1630-EP2311840A1; 1630-EP2311842A2; 1630-EP2314295A1; 1630-EP2314575A1; 1630-EP2314584A1; 1630-EP2314586A1; 1630-EP2314590A1; 1630-EP2314591A1; 1630-EP2314593A1; 1630-EP2316470A2; 1630-EP2316829A1; 1630-EP2316831A1; 1630-EP2316832A1; 1630-EP2316833A1; 1630-EP2316834A1; 1630-EP2316836A1; 1630-EP2371811A2; 1630-EP2374454A1; 1630-EP2374790A1; 1630-EP2374792A1; 1630-EP2377849A2; C00392; D00062; X-3269; 27808-EP2269993A1; 27808-EP2270505A1; 27808-EP2277874A1; 27808-EP2277880A1; 27808-EP2281823A2; 27808-EP2284160A1; 27808-EP2287155A1; 27808-EP2292610A1; 27808-EP2292612A2; 27808-EP2295406A1; 27808-EP2295414A1; 27808-EP2295432A1; 27808-EP2298731A1; 27808-EP2298767A1; 27808-EP2298772A1; 27808-EP2301938A1; 27808-EP2305219A1; 27808-EP2308839A1; 27808-EP2311822A1; 27808-EP2314587A1; AB00443917_06; 065M361; Q407646; Q-101039; SR-01000838849-3; SR-01000838849-4; D-Mannitol, ACS reagent, for microbiology, >=99.0%; D-Mannitol, meets EP, FCC, USP testing specifications; Mannitol, European Pharmacopoeia (EP) Reference Standard; D-Mannitol, BioUltra, >=99.0% (sum of enantiomers, HPLC); Mannitol, United States Pharmacopeia (USP) Reference Standard; D-Mannitol, >=99.9999% (metals basis), for boron determination; Mannitol, Pharmaceutical Secondary Standard; Certified Reference Material; Mannitol; 4-01-00-02841 (Beilstein Handbook Reference)
Manool Manool; 596-85-0; UNII-AT5PJ0PV00; AT5PJ0PV00; NSC165961; (+)-manool; (13R)-manool; CHEMBL4162501; SCHEMBL12658773; CHEBI:76945; ZINC15657750; API0003252; CCG-208417; labda-8(17),14-dien-13(R)-ol; (13R)-labda-8(27),14-dien-13-ol; (13R)-Labda-8(20),14-dien-13-ol; Labda-8 (20),14-dien-13-ol, (13R)-; 596M850; SR-05000002258; SR-05000002258-2; Q15726184; (5S,9S,10S,13R)-labda-8(17),14-dien-13-ol; (3R)-3-methyl-5-[(1R,4aR,8aR)-5,5,8a-trimethyl-2-methylidenedecahydronaphthalen-1-yl]pent-1-en-3-ol; (3R)-3-methyl-5-[(1S,4aS,8aS)-5,5,8a-trimethyl-2-methylenedecahydronaphthalen-1-yl]pent-1-en-3-ol; (3R)-5-[(1S,4aS,8aS)-5,5,8a-trimethyl-2-methylene-decalin-1-yl]-3-methyl-pent-1-en-3-ol; (R)-3-methyl-5-((1S,4aS,8aS)-5,5,8a-trimethyl-2-methylenedecahydronaphthalen-1-yl)pent-1-en-3-ol; 1-Naphthalenepropanol, .alpha.-ethenyldecahydro-.alpha.,5,5,8a-tetramethyl-2-methylene-, (4aS)-
Mechlorethamine 2-Chloro-N-(2-chloroethyl)-N-methylethanamine; Mechlorethamine; Chlormethine; Nitrogen mustard; Chlorethazine; Mustine; Mustargen; Cloramin; 51-75-2; Mecloretamina; Bis(2-chloroethyl)methylamine; Caryolysine; Embichin; Mechloroethamine; Dichlor amine; 2-Chloro-N-(2-chloroethyl)-N-methylethanamine; Methylbis(2-chloroethyl)amine; 2,2'-Dichloro-N-methyldiethylamine; Nitrogranulogen; Antimit; N-Methyl-bis(2-chloroethyl)amine; Bis(beta-chloroethyl)methylamine; Methylbis(beta-chloroethyl)amine; N-Methyl lost; N-Methyl-lost; N-Methyl-bis(beta-chloroethyl)amine; Ethanamine, 2-chloro-N-(2-chloroethyl)-N-methyl-; Mustine note; Di(2-chloroethyl)methylamine; Methyldi(2-chloroethyl)amine; beta,beta'-Dichlorodiethyl-N-methylamine; N,N-Bis(2-chloroethyl)methylamine; Stickstofflost (ebewe); Mecloretamina [Italian]; N,N-Di(chloroethyl)methylamine; HN-2; N-Methyl-lost [German]; N-Lost; Clormetina [INN-Spanish]; Nitrogen mustard (HN-2); 2,2'-Dichlorodiethyl-methylamine; NSC 762; Chlormethinum [INN-Latin]; N-Methyl-bis-chloraethylamin; N-Methyl-2,2'-dichlorodiethylamine; ENT-25294; TL 146; HN2; Chloramine (the nitrogen mustard); Chlormethine [INN:BAN]; UNII-50D9XSG0VR; MBA; Carolysine; CCRIS 447; Mebichloramine; N-Methyl-bis-chloraethylamin [German]; Embechine; T-1024; Diethylamine, 2,2'-dichloro-N-methyl-; CHEBI:28925; HSDB 5083; EINECS 200-120-5; T 1024; BRN 0605323; 50D9XSG0VR; N-METHYL-DI(2-CHLORO)-ETHYLAMINE; N-methylbis(2-chloroethyl)amine; bis(2-chloroethyl)(methyl)amine; HAWPXGHAZFHHAD-UHFFFAOYSA-N; C5H11Cl2N; Clormetina; .Beta.,.beta.'-Dichlorodiethyl-N-methylamine; AB00052033_05; Valchlor; Mechlorethanamine; Me chloroethamine; Methylchlorethamine; Chlormethine (INN); NSC-128663; Nitol (*Hydrochloride*); Mitoxine (*Hydrochloride*); Ledaga; Bis-(2-chloroethyl)methylamine; SR-05000001664; Bis(beta-chloroethyl) methylamine; Stickstofflost (*Hydrochloride*); Eraso (Salt/Mix); Nitol (Salt/Mix); Hn2 (amine); N,N-Bis(2-chloroethyl)-N-methylamine; Embichin (Salt/Mix); Dichloren (Salt/Mix); Chlormethinehydrochloride; Spectrum_000889; Caryolysin (Salt/Mix); Caryolysine (Salt/Mix); Spectrum2_000448; Spectrum3_000484; Spectrum4_000924; Spectrum5_001702; bis(chloroethyl)methylamine; CHEMBL427; Epitope ID:116224; cid_4033; SCHEMBL3861; 2-chloro-N-(2-chloroethyl)-N-methyl-ethanamine; Bis(b-chloroethyl)methylamine; BSPBio_001947; KBioGR_001448; KBioSS_001369; DivK1c_000759; SPECTRUM1500375; SPBio_000496; Methyl-bis(2-chloroethyl)amine; GTPL7218; DTXSID2020975; HMS502F21; KBio1_000759; KBio2_001369; KBio2_003937; KBio2_006505; KBio3_001447; N-methyldi-(2-chloroethyl)amine; bis(2-chloro-ethyl)-methyl-amine; bis-(2-chloro-ethyl)-methylamine; NINDS_000759; BDBM200297; Bis(.beta.-chloroethyl)methylamine; HMS1920J15; HMS2091B04; Methylbis(.beta.-chloroethyl)amine; Pharmakon1600-01500375; bis-(2-chloro-ethyl)-methyl-amine; ZINC2539484; CCG-39885; NSC757087; STL484282; AKOS006229862; N-Methyl-bis(.beta.-chloroethyl)amine; DB00888; LS-7559; MCULE-6341452542; NSC-757087; IDI1_000759; NCGC00091835-02; NCGC00091835-03; NCGC00091835-04; NCGC00091835-05; NCGC00091835-06; NCGC00091835-07; NCGC00091835-08; NCGC00091835-09; N,N-Bis(2-chloroethyl)-N-methylamine #; NCI60_041682; U601; SBI-0051432.P003; A8064; C07115; D07671; 13159-EP2277876A1; 13159-EP2292614A1; 13159-EP2295426A1; 13159-EP2295427A1; 13159-EP2308833A2; 13159-EP2308861A1; 13159-EP2311825A1; 13159-EP2311842A2; 13159-EP2316834A1; 13159-EP2374454A1; 49304-EP2272827A1; 49304-EP2311840A1; AB00052033-04; 055M867; Q418011; 1, 5-Dichloro-3-methyl-3-azapentane hydrochloride; SR-05000001664-1; BRD-K12829205-001-03-0; Mechlorethamine; T-1024
Medroxyprogesterone acetate (6alpha)-17-(Acetyloxy)-6-methylpregn-4-ene-3,20-dione; Medroxyprogesterone 17-acetate; U 8839
Medrysone (6 alpha, 11 beta)-11-Hydroxy-6-methylpregn-4-ene-3,20-dione; Medrysone; U-8471
Mefenamic acid 2-[(2,3-Dimethylphenyl)amino]benzoic acid; Mefenamic acid; Ac. mefenamico [Italian]
Melatonin N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide; Melatonin; 73-31-4; Melatonine; N-Acetyl-5-methoxytryptamine; Circadin; 5-Methoxy-N-acetyltryptamine; N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide; N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide; Melatol; Melatonex; Melovine; Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-; N-[2-(5-methoxyindol-3-yl)ethyl]acetamide; UNII-JL5DK93RCL; N-(2-(5-Methoxyindol-3-yl)ethyl)acetamide; N-acetyl-5-methoxy-tryptamine; NSC 113928; CCRIS 3472; CHEMBL45; EINECS 200-797-7; JL5DK93RCL; Acetamide, N-(2-(5-methoxyindol-3-yl)ethyl)-; BRN 0205542; CHEBI:16796; DRLFMBDRBRZALE-UHFFFAOYSA-N; Acetamide, N-[2-(5-methoxyindol-3-yl)ethyl]-; Melatonine, 99%; Acetamide, N-(2-(5-methoxy-1H-indol-3-yl)ethyl)-; NSC-56423; NSC113928; NSC-113928; CAS-73-31-4; NCGC00015680-11; 3-(n-acetyl-2-aminoethyl)-5-methoxyindole; DSSTox_CID_2421; DSSTox_RID_76585; DSSTox_GSID_22421; Melapure; Posidorm; WLN: T56 BMJ D2MV1 GO1; [3H]melatonin; Melatonina (TN); [3H]-melatonin; ML1; SMR000326666; N-(2-(5-methoxyindol-3-yl)ethyl)-Acetamide; N-[2-(5-methoxyindol-3-yl)ethyl]-Acetamide; N-[2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide; SR-01000075559; [3H]MLT; Acetamide, N-(2-(5-methoxy-1H-indol-3-yl)ethyl)- (9CI); Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]- (9CI); Melatonine; Guna-dermo; HSDB 7509; PREVENTION 2 (MELATONIN); PREVENTION 3 (MELATONIN); PREVENTION 4 (MELATONIN); PREVENTION 5 (MELATONIN); Melatonin (JAN); Melatonin (MLT); TNP00300; Prestwick_312; N-[2-(5-Methoxy-1H-indol-3-yl)-ethyl]-acetamide; 8041-44-9; PubChem18245; Spectrum_000185; Guna-dermo (Salt/Mix); Prestwick0_000458; Prestwick1_000458; Prestwick2_000458; Prestwick3_000458; Spectrum2_001344; Spectrum3_001393; Spectrum4_000066; Spectrum5_001745; Lopac-M-5250; M1105; ChemDiv2_003916; M 5250; Melatonex, 73-31-4; Melatonin, >=99.5%; Lopac0_000787; Oprea1_104553; Oprea1_814234; PREVENTION 1 (MELATONIN) (PREVENTION 1); SCHEMBL19018; BSPBio_000536; BSPBio_003006; GTPL224; KBioGR_000591; KBioSS_000665; 5-22-12-00042 (Beilstein Handbook Reference); Acetamide, {N-[2-(5-methoxyindol-3-yl)ethyl]-}; KSC498C4R; MLS000859594; MLS001055382; MLS001240204; ARONIS24462; BIDD:ER0618; DivK1c_000353; SPECTRUM1500690; SPBio_001527; SPBio_002475; Melatonin (synth.) ultra-pure; ACE073; BDBM9019; BPBio1_000590; GTPL1357; Acetamide, {N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-}; DTXSID1022421; CTK3J8148; HMS501B15; KBio1_000353; KBio2_000665; KBio2_003233; KBio2_005801; KBio3_002226; ZINC57060; BCI-049; Melatonin 1.0 mg/ml in Methanol; NINDS_000353; HMS1380B22; HMS1569K18; HMS1921E04; HMS2089F09; HMS2096K18; HMS2233D23; HMS3262M16; HMS3370J20; HMS3413P14; HMS3654A22; HMS3677P14; HMS3713K18; Melatonin (synth.) standard-grade; ACT03490; BCP28154; HY-B0075; KS-00000GX9; NSC56423; Tox21_110195; Tox21_201527; Tox21_302926; Tox21_500787; ANW-42685; CCG-38837; CM-539; HSCI1_000400; KM1545; Melatonin, powder, >=98% (TLC); MFCD00005655; SBB003265; STK386880; Melatonin 100 microg/mL in Methanol; AKOS000276269; Tox21_110195_1; CS-1769; DB01065; J5.258B; KS-1454; LP00787; LS-1623; MCULE-1497884152; RTC-063565; SDCCGMLS-0065812.P001; SDCCGMLS-0065812.P002; SDCCGSBI-0050765.P003; IDI1_000353; IDI1_002631; KS-000048J8; SMP2_000309; N-acetyl-5-methoxy-tryptamine Melatonine; NCGC00015680-01; NCGC00015680-02; NCGC00015680-03; NCGC00015680-04; NCGC00015680-05; NCGC00015680-06; NCGC00015680-07; NCGC00015680-08; NCGC00015680-09; NCGC00015680-10; NCGC00015680-12; NCGC00015680-13; NCGC00015680-14; NCGC00015680-15; NCGC00015680-16; NCGC00015680-18; NCGC00090727-01; NCGC00090727-02; NCGC00090727-03; NCGC00090727-04; NCGC00090727-05; NCGC00090727-06; NCGC00090727-07; NCGC00090727-08; NCGC00090727-09; NCGC00256404-01; NCGC00259077-01; NCGC00261472-01; 4CN-3100; AC-10019; AK110931; NCI60_004378; SC-16475; ST057260; AB0007332; AB2000011; TC-063565; AB00053279; EU-0100787; FT-0628191; FT-0658928; S1204; ST24031293; SW196607-4; C01598; D08170; J10164; AB00053279-10; AB00053279_12; {N-[2-(5-methoxyindol-3-yl)ethyl]-} Acetamide; 005M655; L001261; N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-Acetamide; Q180912; SR-01000075559-1; SR-01000075559-6; SR-01000075559-7; SR-01000075559-8; {N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-} Acetamide; BRD-K97530723-001-07-6; BRD-K97530723-001-11-8; F1929-1777; Melatonin, British Pharmacopoeia (BP) Reference Standard; 0E2B08C1-B325-45B1-8939-6F9081EFDFA4; Acetamide, N-[2-(5-methoxyindol-3-yl)ethyl]- (6CI,8CI); Melatonin, United States Pharmacopeia (USP) Reference Standard; Melatonin, Pharmaceutical Secondary Standard; Certified Reference Material; Melatonin solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; Melatonin; 5-22-12-00042 (Beilstein Handbook Reference)
Meloxicam
Melphalan 4-[Bis(2-chloroethyl)amino]-L-phenylalanine; melphalan; 148-82-3; Alkeran; Melfalan; L-PAM; Phenylalanine mustard; L-Sarcolysine; L-Sarcolysin; L-Phenylalanine mustard; p-L-Sarcolysin; Levofalan; Levopholan; Melphalanum; Levofolan; Melfalano; L-Sarkolysin; 4-[Bis(2-chloroethyl)amino]-L-phenylalanine; Phenylalanine nitrogen mustard; p-Di-(2-chloroethyl)amino-L-phenylalanine; p-Bis(beta-chloroethyl)aminophenylalanine; 3-(p-(Bis(2-chloroethyl)amino)phenyl)-L-alanine; Melfalano [INN-Spanish]; Melphalanum [INN-Latin]; p-N-Bis(2-chloroethyl)amino-L-phenylalanine; 4-(Bis(2-chloroethyl)amino)-L-phenylalanine; 3-p-(Di(2-chloroethyl)amino)-phenyl-L-alanine; NCI-C04853; L-3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine; Alanine Nitrogen Mustard; CB 3025; Rcra waste number U150; NSC-8806; CCRIS 374; UNII-Q41OR9510P; CB-3025; SK-15673; CHEBI:28876; (2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid; HSDB 3234; p-N,N-bis(2-chloroethyl)amino-L-phenylalanine; EINECS 205-726-3; CHEMBL852; RCRA waste no. U150; NSC 241286; BRN 2816456; L-3-(para-(Bis(2-chloroethyl)amino)phenyl)alanine; SK 15673; ALKERAN (TN); SGDBTWWWUNNDEQ-LBPRGKRZSA-N; Q41OR9510P; Melphalan, 94%; Alanine, 3-(p-(bis(2-chloroethyl)amino)phenyl)-, L-; Alanine, 3-[p-[bis(2-chloroethyl)amino]phenyl]-, L-; NCGC00090757-02; 4-(Bis(2-chloroethyl)amino)phenylalanine; NSC 8806; DSSTox_CID_804; L-Phenylalanine, 4-(bis(2-chloroethyl)amino)-; DSSTox_RID_75797; DSSTox_GSID_20804; W-108096; Phenylalanine, 4-[bis(2-chloroethyl)amino]-; Evomela; (S)-2-amino-3-(4-(bis(2-chloroethyl)amino)phenyl)propanoic acid; p-L-sarcolysine; (2s)-2-amino-3-(4-[bis(2-chloroethyl)amino]phenyl)propanoic acid; p-N-Di(chloroethyl)aminophenylalanine; NSC8806; 4-[Bis(2-chloroethyl)amino]phenylalanine; CAS-148-82-3; SMR000058720; L-Phenylalanine, 4-[bis(2-chloroethyl)amino]-; Melphalan [USAN:INN:BAN:JAN]; phenylalanine nitrogen mu stard; (2S)-2-amino-3-{4-[bis(2-chloroethyl)amino]phenyl}propanoic acid; NSC241286; Melphalan, powder; NSC-241286; Prestwick_1006; Melphalan [USAN:USP:INN:BAN:JAN]; p-N-di(chloroethyl)aminophenylala nine; Spectrum_000397; 3025 C.B.; Spectrum2_000074; Spectrum3_000684; Spectrum4_000882; Spectrum5_001601; 3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine; Epitope ID:141802; 4-[Bis-(2-chloroethyl)amino]-L-phenylalanine; TRANSGENIC MODEL EVALUATION (MELPHALAN); SCHEMBL5872; BSPBio_002407; KBioGR_001284; KBioSS_000877; 4-14-00-01689 (Beilstein Handbook Reference); MLS001333666; MLS002153368; BIDD:GT0044; DivK1c_000653; SPECTRUM1500382; SPBio_000287; Melphalan (JP17/USP/INN); GTPL7620; ZINC1673; DTXSID6020804; NIOSH/AY3360000; TRANSGENIC LEP (MELPHALAN) (SEE ALSO MELPHALAN); CTK5E7915; HMS502A15; KBio1_000653; KBio2_000877; KBio2_003445; KBio2_006013; KBio3_001627; L-phenylalanine mustard (L-PAM); 3025 c.b; NINDS_000653; HMS2090B09; HMS2091B16; HMS2235D21; Pharmakon1600-01500382; KS-00001D9Q; Tox21_111010; Tox21_202522; BDBM50025837; CCG-39704; DL-442; LS-865; MELPHALAN (SEE ALSO TRANSGENIC MODEL EVALUATION (MELPHALAN)); NSC757098; s8266; AKOS015895374; Alkeran; L-Phenylalanine mustard; L-PAM; Tox21_111010_1; API0003288; CS-3120; DB01042; NSC-757098; IDI1_000653; SMP2_000174; NCGC00090757-01; NCGC00090757-03; NCGC00090757-04; NCGC00090757-05; NCGC00090757-06; NCGC00260071-01; 8057-25-8; AS-13314; CC-30199; H877; HY-17575; LS-15868; SBI-0052787.P003; AB0005221; AB2000419; AY33600000; FT-0603357; 4-[bis(2-chloroethyl)-amino]-L-phenylalanine; 4-[bis(2-chloroethyl)-amino]-l-phenyl-alanine; 4-[bis(2-chloroethyl)amino]-(L)-phenylalanine; C07122; D00369; K-4728; AB00053282-07; AB00053282-08; AB00053282_09; 148M823; A808810; Alanine, 3-(p-(bis(2-chloroethyl)amino)phenyl)-; C-19011; SR-05000001667; Q2298283; SR-05000001667-1; BRD-K87827419-001-02-8; 2-amino-3-[4-bis(2-chloroethyl)amino]phenylpropanoic acid; UNII-A960M0G5TP component SGDBTWWWUNNDEQ-LBPRGKRZSA-N; (2S)-2-azanyl-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid; 2-Amino-3-{4-[bis-(2-chloro-ethyl)-amino]-phenyl}-propionic acid; (S)-2-Amino-3-{4-[bis-(2-chloro-ethyl)-amino]-phenyl}-propionic acid; 2-Amino-3-{4-[bis-(2-chloro-ethyl)-amino]-phenyl}-propionic acid(L-PAM); 2-Amino-3-{4-[bis-(2-chloro-ethyl)-amino]-phenyl}-propionic acid (Melphalan); 2-Amino-3-{4-[bis-(2-chloro-ethyl)-amino]-phenyl}-propionic acid(Melphalan); Melphalan; 3025 C.B.
Menadiol sodium diphosphate 2-Methylbis(dihydrogen phosphate)-1,4-naphthalenediol tetrasodium salt; Menadiol sodium diphosphate anhydrous [USAN]; EINECS 205-012-1
Meprobamate 2-Methyl-2-propyl-1,3-propanediol dicarbamate; Meprobamate; 3P Bamate
Mercaptopurine 1,7-Dihydro-6H-purine-6-thione; 6-Mercaptopurine; mercaptopurine; 50-44-2; Mercapurin; Purinethol; 6-Thiopurine; Leukerin; Leupurin; Mercaleukin; 6-Thioxopurine; Puri-Nethol; Ismipur; 7H-purine-6-thiol; Mern; 6-Thiohypoxanthine; 6-Mercaptopurin; 6-Purinethiol; Purimethol; Purinethiol; 6-MP; Purine-6-thiol; 1,9-dihydro-6H-purine-6-thione; 3H-Purine-6-thiol; 6 MP; 9H-Purine-6-thiol; Mercaleukim; Hypoxanthine, thio-; Mercaptopurine (6-MP); 3,7-dihydropurine-6-thione; 6H-Purine-6-thione, 1,7-dihydro-; 1,7-Dihydro-6H-purine-6-thione; Mercaptopurin; Mercaptopurina; Mercaptopurinum; Merkaptopuryna; Xaluprine; 6-Merkaptopurin; Purine, 6-mercapto-; Purine-6-thione; 9H-Purine-6(1H)-thione; Mercaptopurine anhydrous; Purine-6(1H)-thione; Mercaptopurine (VAN); NCI-C04886; Mercaptopurin [German]; Merkaptopuryna [Polish]; 7-Mercapto-1,3,4,6-tetrazaindene; 6-Merkaptopurin [Czech]; Mercaptopurine (anhydrous); 1H-Purine, 6-mercapto-; NSC 755; Mercaptopurinum [INN-Latin]; Mercaptopurina [INN-Spanish]; U-4748; NSC-755; UNII-PKK6MUZ20G; C5H4N4S; CCRIS 2761; NSC755; HSDB 3235; Purinethol (TN); EINECS 200-037-4; PKK6MUZ20G; 1,9-dihydropurine-6-thione; CHEBI:2208; GLVAUDGFNGKCSF-UHFFFAOYSA-N; 157930-13-7; DSSTox_CID_810; DSSTox_RID_75801; DSSTox_GSID_20810; 157930-14-8; Purixan; thiohypoxanthine; Leupu rin; CAS-50-44-2; SMR000544948; Mercaptopurine, 6-; Mercaptopurine (INN); SR-05000001925; NCIMech_000025; 1H-purine-6(7H)-thione; 9H-Purin-6-yl hydrosulfide; Mercaptopurine; Mercaptopurine [USAN:USP:INN]; 6-Mercaptoadenine; PubChem9680; Spectrum_000921; ACMC-1AUNA; Spectrum2_000060; Spectrum3_000491; Spectrum4_000857; Spectrum5_000950; M0063; H-Purine-6(1H)-thione; Leukerin, 99% - Carc; Azathioprine EP Impurity B; SCHEMBL3893; CHEMBL1425; BSPBio_001981; KBioGR_001493; KBioGR_002363; KBioSS_001401; KBioSS_002366; AG-670/31547064; KSC270A9L; MLS001066623; MLS001304020; MLS001304953; MLS006011869; ARONIS27054; DivK1c_000493; SPECTRUM1500387; SPBio_000219; GTPL7226; SCHEMBL2790086; 7H-Purin-6-yl hydrosulfide #; DTXSID0020810; SCHEMBL12683725; CHEBI:50667; CHEBI:94796; CTK1H0095; CTK8A7797; HMS501I15; KBio1_000493; KBio2_001401; KBio2_002363; KBio2_003969; KBio2_004931; KBio2_006537; KBio2_007499; KBio3_001481; KBio3_002842; 7-Mercapto-1,4,6-tetrazaindene; cMAP_000033; NINDS_000493; Purinethol; 6-mercaptopurine; 6-MP; 3,7-dihydro-6H-purine-6-thione; 6,7-dihydro-3H-purine-6-thione; HMS1920L07; HMS2091B20; HMS2236L06; HMS3259N03; HMS3369M05; HMS3651G07; HMS3713N10; HMS3747A17; Pharmakon1600-01500387; ACT11542; CID 4071; EBD16256; KS-000048JV; ZINC4658290; Tox21_111158; Tox21_202591; 6450AJ; ANW-30999; ANW-57555; BBL033743; BDBM50423778; CCG-35344; CCG-39915; EBD540779; LS-141; NSC759614; s1305; SBB037953; STK727062; STL257085; 6-Mercaptopurine, analytical standard; WLN: T56 BM DN FN HNJ ISH; AKOS000170222; AKOS000275858; AKOS005224624; AKOS008901311; AKOS016903205; Tox21_111158_1; AM81386; CM-1232; CS-1499; DB01033; LS20858; MCULE-4811219863; NC00613; NSC-759614; RTR-021065; IDI1_000493; NCGC00091641-02; NCGC00091641-03; NCGC00091641-04; NCGC00094717-01; NCGC00094717-02; NCGC00094717-03; NCGC00094717-05; NCGC00094717-06; NCGC00188973-01; NCGC00260139-01; AC-11464; AS-13109; CPD000544948; H348; HY-13677; NCI60_041653; SAM002589937; SC-04873; SMR004703503; ST086505; ST086506; SBI-0051437.P004; AB0013000; AB0119973; AB2000041; DB-026398; TR-021065; 4CH-021382; BB 0241023; FT-0083571; FT-0621175; SW199090-2; EN300-61517; 1766-EP2270008A1; 1766-EP2272827A1; 1766-EP2272832A1; 1766-EP2277876A1; 1766-EP2292614A1; 1766-EP2292617A1; 1766-EP2295409A1; 1766-EP2295426A1; 1766-EP2295427A1; 1766-EP2298768A1; 1766-EP2298778A1; 1766-EP2308833A2; 1766-EP2308855A1; 1766-EP2308861A1; 1766-EP2314590A1; 1766-EP2316834A1; 1766-EP2374454A1; 50M442; C01756; C02380; D04931; W-5114; 15150-EP2272827A1; 15150-EP2275420A1; 15150-EP2295055A2; 15150-EP2295416A2; 15150-EP2298748A2; 15150-EP2298764A1; 15150-EP2298765A1; 15150-EP2305642A2; 15150-EP2305679A1; 15150-EP2308833A2; 15150-EP2311453A1; 15150-EP2311825A1; 15150-EP2311840A1; 15150-EP2311842A2; 15150-EP2316832A1; 15150-EP2316833A1; 21414-EP2270006A1; 21414-EP2270014A1; 21414-EP2272509A1; 21414-EP2272847A1; 21414-EP2275413A1; 21414-EP2277874A1; 21414-EP2284158A1; 21414-EP2287156A1; 21414-EP2287159A1; 21414-EP2295439A1; 21414-EP2311818A1; 21414-EP2314295A1; AB00171799_05; AB00641894-03; AB00641894-04; AB00641894_05; AB00876276-13; 233D552; 462M721; 599M524; A828129; Q418529; SR-05000001925-1; SR-05000001925-2; W-105961; purine antimetabolite: inhibits nucleic acid replication; 1,9-Dihydropurine-6-thione DISCONTINUED, see M225450; Mercaptopurine; 7H-Purine-6-thiol; Azathioprine BP Impurity B; Mercaptopurine; U-4748
Mercurochrome (2',7'-Dibromo-3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-4'-yl)hydroxymercury sodium salt (1:2); Merbromin; Asceptichrome
Mercury amide chloride Mercuric ammonium chloride; Aminomercuric chloride
Mesalamine 5-Amino-2-hydroxybenzoic acid; Mesalamine; 4-14-00-02058 (Beilstein Handbook Reference)
Metformin N,N-Dimethylimidodicarbonimidic diamide; Metformin; Diabetosan
Methacycline (4S,4aR,5S,5aR,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-2-naphthacenecarboxamide; Methacycline; Bialatan
Methamphetamine (alphaS)-N,alpha-Dimethylbenzeneethanamine; METHAMPHETAMINE; Metamfetamine; d-Methamphetamine; d-Deoxyephedrine; d-Desoxyephedrine; d-N-Methylamphetamine; Metamphetamine; d-Methylamphetamine; Methylamphetamine; d-Phenylisopropylmethylamine; N-Methylamphetamine; (S)-Methamphetamine; Norodin; (+)-Methylamphetamine; d-(S)-Methamphetamine; D-1-Phenyl-2-methylaminopropane; Desyphed; (+)-N-Methylamphetamine; (S)-Methylamphetamine; (+)-(S)-Deoxyephedrine; Methyl-beta-phenylisopropylamine; 1-Phenyl-2-methylaminopropane; (S)-(+)-Deoxyephedrine; MetamfetamiMetamfetaminum; Stimulex; Speed; (+)-methamphetamine; 537-46-2; (2S)-N-methyl-1-phenylpropan-2-amine; MetanfetamiS-(+)-Methamphetamine; (S)-N,alpha-Dimethylbenzeneethanamine; D-N,alpha-dimethylphenethylamine; Metamfetaminum [INN-Latin]; Metamfetamina [INN-Spanish]; Metanfetamina [INN-Spanish]; Methamphetaminum [INN-Latin]; (+)-2-(N-Methylamino)-1-phenylpropane; Meth; Metamfetamine [INN]; N-Methyl-beta-phenylisopropylamine; Methamphetaminum [JP]; 1-Phenyl-2-methylamino-propan [German]; Metamfetaminum [Latin]; (+)-N,alpha-Dimethylphenethylamine; d-1-Phenyl-2-methylaminopropan [German]; Metanfetamina [Spanish]; (+)-N,alpha-Dimethyl-beta-phenylethylamine; D-1-Phenyl-2-methylaminopropan; 2S-(+)-Methamphetamine; dextromethamphetamine; (S)-(+)-Methamphetamine; (+)-(S)-N-alpha-Dimethylphenethylamine; N-Methyl-beta-phenylisopropylamin [German]; NSC 25115; (S)-N,alpha-Dimethylbenzeneethanoamine; UNII-44RAL3456C; CHEBI:6809; (S)-(+)-N,alpha,dimethylphenethylamine; Metamfetamine (INN); (alphaS)-N,alpha-dimethylbenzeneethanamine; HSDB 3359; Benzeneethanamine, N,alpha-dimethyl-, (S)-; Methyl-.beta.-phenylisopropylamine; d-N,.alpha.-Dimethylphenethylamine; Methamphetamine hydrochloride; EINECS 208-668-7; Phenethylamine, N,alpha-dimethyl-, (+)-; DEA No. 1105; Benzeneethanamine, N,alpha-dimethyl-, (+)-; MYWUZJCMWCOHBA-VIFPVBQESA-N; 44RAL3456C; Benzeneethanamine, N,alpha-dimethyl-, (alphaS)-; 1-Phenyl-2-methylamino-propan; NSC-25115; N-Methyl-beta-phenylisopropylamin; Crank; Methamphetamine, its salts, isomers, and salts of its isomers; Methamphetaminum; Crystal Meth; Phenethylamine, N,alpha-dimethyl-, (S)-(+)-; Meth (Street Name); ICE [Street Name]; Crank [Street Name]; Speed [Street Name]; Crystal Meth [Street Name]; N-Methyl-1-phenyl-2-propanamine; (+ )-Methylamphetamine; C10H15N; B40; Benzeneethanamine, N,.alpha.-dimethyl-, (S)-; Phenethylamine, N,.alpha.-dimethyl-, (S)-(+)-; Epitope ID:178090; intra-venous methamphetamine; Benzeneethanamine,.alpha.-dimethyl-, (S)-; d-N,a-dimethylphenethylamine; SCHEMBL42615; Phenethylamine,.alpha.-dimethyl-, (S)-(+)-; CHEMBL1201201; DTXSID8037128; WLN: 1MY1&1R -D; N,I+/--Dimethyl-phenethyl amine; Desyphed hydrochloride (Salt/Mix); NSC25115; ZINC6021043; N-Methyl-1-phenyl-2-propanamine #; BDBM50359499; PDSP1_001404; PDSP1_001405; PDSP2_001388; PDSP2_001389; (+)-N,.alpha.-Dimethylphenethylamine; (S)-N-methyl-1-phenylpropan-2-amine; DB01577; J6.362B; Desoxyephedrine hydrochloride (Salt/Mix); methyl[(2S)-1-phenylpropan-2-yl]amine; Phenethylamine,.alpha.-dimethyl-, (+)-; (+)-(S)-N-.alpha.-Dimethylphenethylamine; Benzeneethanamine,.alpha.-dimethyl-, (+)-; LS-103331; Phenethylamine, N,.alpha.-dimethyl-, (+)-; Benzeneethanamine, N,.alpha.-dimethyl-, (+)-; C07164; D08187; (+)-N,.alpha.-Dimethyl-.beta.-phenylethylamine; Q191924; Phenethylamine, N,alpha-dimethyl-, (S)-(+)- (8CI); Benzeneethanamine, N,alpha-dimethyl-, (alphaS)- (9CI); UNII-13ZT6YG5SD component MYWUZJCMWCOHBA-VIFPVBQESA-N; (+)-N,.alpha.-Dimethylphenethylamine hydrochloride (Salt/Mix); 139-47-9; S(+)-Methamphetamine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; Methamphetamine; Benzeneethanamine, N,alpha-dimethyl-, (+)-
Methaqualone 2-Methyl-3-(2-methylphenyl)-4(3H)-quinazdinone; Methaqualone; R-148
Methenamine 1,3,5,7-Tetraazatricyclo[3.3.1.137]decane; Hexamethylene tetramine; Aceto HMT
Methionine D- D-Methionine; D-Methionine; 348-67-4; H-D-Met-OH; (R)-Methionine; methionine; D-Methionin; D-Metionien; METHIONINE, D-; (R)-2-amino-4-(methylthio)butanoic acid; R-Methionine; MRx-1024; UNII-868496F25R; (2R)-2-amino-4-(methylsulfanyl)butanoic acid; D-2-Amino-4-(methylthio)butyric acid; D-2-Amino-4-(methylthio)butanoic acid; CHEBI:16867; Methionine D-; FFEARJCKVFRZRR-SCSAIBSYSA-N; MFCD00002622; MED; D-Methionine, 99+%; (R)-2-Amino-4-(methylmercapto)butyric acid; 868496F25R; D-Metionien [Australian]; EINECS 206-483-6; NSC 45689; L-Methionine; Methionine d-form; D-Met; D-Met-OH; bmse000450; D-Methionine; MRX-1024; KSC222Q8N; SCHEMBL126688; CHEMBL1234268; CTK1C2886; DTXSID90883369; D-Methionine, >=98% (HPLC); ACT04819; KS-00000A8Q; ZINC1532766; ANW-28004; SBB006710; AKOS015852500; AC-8661; AM81977; CS-7880; DB02893; EBD2198096; RTR-014410; NCGC00163337-01; (R)-2-Amino-4-(methylthio)butyric acid; AC-12369; DS-15125; HY-13694; SC-09743; D-Methionine, puriss., >=99.0% (NT); DB-038140; TR-014410; FT-0625547; M0102; ST24046407; C00855; Z-3842; 93481-EP2295437A1; 93481-EP2298775A1; 93481-EP2305641A1; 348M674; J-300192; Q-101531; Q27093862; UNII-73JWT2K6T3 component FFEARJCKVFRZRR-SCSAIBSYSA-N; Methionine D-; EINECS 206-483-6
Methohexital 1-Methyl-5-(1-methyl-2-pentyn-1-yl)-5-(2-propen-1-yl)-2,4,6(1H,3H,5H)-pyrimidinetrione; Methohexital; EINECS 205-798-6